Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» kidney transplants
kidney transplants
FDA approves Merck's letermovir to prevent CMV in kidney transplant recipients
FDA approves Merck's letermovir to prevent CMV in kidney transplant recipients
Healio
Merck
FDA
letermovir
CMV
kidney transplants
Prevymis
Flag link:
Talaris lays off 95% of workforce, C-suite as kidney transplant company fails to find a savior
Talaris lays off 95% of workforce, C-suite as kidney transplant company fails to find a savior
Fierce Biotech
Talaris Therapeutics
clinical trials
kidney transplants
Flag link:
Hookipa halts spending on cytomegalovirus vaccine after seeing phase 2 data
Hookipa halts spending on cytomegalovirus vaccine after seeing phase 2 data
Fierce Biotech
Hookipa
CMV
vaccines
HB-101
kidney transplants
Flag link:
Merck tees up Prevymis filing in kidney transplant recipients after phase 3 trial win
Merck tees up Prevymis filing in kidney transplant recipients after phase 3 trial win
Fierce Pharma
Merck
Prevymis
kidney transplants
clinical trials
CMV
IDWeek
Flag link:
Talaris is Rapidly Expanding as it Speeds Toward a First BLA
Talaris is Rapidly Expanding as it Speeds Toward a First BLA
BioSpace
Talaris Therapeutics
cell therapy
kidney transplants
chimerism
Flag link:
Veloxis wins $1.3B buyout deal, and the new owner plans to follow up with new deals
Veloxis wins $1.3B buyout deal, and the new owner plans to follow up with new deals
Endpoints
Asahi Kasei
Veloxis Pharmaceuticals
M&A
organ rejection
Envarsus XR
kidney transplants
Flag link:
Lawmakers, Advocates Push To Extend Medicare's Coverage Of Kidney Transplant Drugs
Lawmakers, Advocates Push To Extend Medicare's Coverage Of Kidney Transplant Drugs
NPR
kidney transplants
Medicare
Flag link:
District Court Rules for FDA in Battle Over the Scope of 3-Year Exclusivity in the Context of Dueling Tacrolimus NDAs
District Court Rules for FDA in Battle Over the Scope of 3-Year Exclusivity in the Context of Dueling Tacrolimus NDAs
FDA Law Blog
FDA
exclusivity
Astellas
Veloxis
kidney transplants
Envarsus
Flag link:
Data from Alexion's Soliris Study
Data from Alexion's Soliris Study
Yahoo/Zacks
Alexion
acute antibody-mediated rejection
kidney transplants
transplant
Soliris
Flag link:
When a Medical Device Warning Was Ignored, the Patient Died
When a Medical Device Warning Was Ignored, the Patient Died
kidney transplants
Flag link:
Bristol-Myers Squibb Receives Complete Response Letter from FDA for Belatacept
Bristol-Myers Squibb Receives Complete Response Letter from FDA for Belatacept
Yahoo/BusinessWire
Bristol-Myers Squibb
organ transplants
kidney transplants
Flag link: